CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $3.48 billion. The enterprise value is $1.77 billion.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 85.35 million shares outstanding. The number of shares has increased by 5.11% in one year.
| Current Share Class | 85.35M |
| Shares Outstanding | 85.35M |
| Shares Change (YoY) | +5.11% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 73.23% |
| Float | 83.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.65 |
| Forward PS | 62.67 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.64, with a Debt / Equity ratio of 0.12.
| Current Ratio | 21.64 |
| Quick Ratio | 21.55 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.07% and return on invested capital (ROIC) is -10.04%.
| Return on Equity (ROE) | -13.07% |
| Return on Assets (ROA) | -9.57% |
| Return on Capital (ROIC) | -10.04% |
| Revenue Per Employee | $498,351 |
| Profits Per Employee | -$588,683 |
| Employee Count | 407 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.12 million in taxes.
| Income Tax | 3.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.07% in the last 52 weeks. The beta is 1.63, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -39.07% |
| 50-Day Moving Average | 48.37 |
| 200-Day Moving Average | 53.83 |
| Relative Strength Index (RSI) | 33.92 |
| Average Volume (20 Days) | 1,904,710 |
Short Selling Information
The latest short interest is 18.15 million, so 21.27% of the outstanding shares have been sold short.
| Short Interest | 18.15M |
| Short Previous Month | 19.39M |
| Short % of Shares Out | 21.27% |
| Short % of Float | 21.62% |
| Short Ratio (days to cover) | 9.96 |
Income Statement
In the last 12 months, CRSP had revenue of $202.83 million and -$239.59 million in losses. Loss per share was -$2.90.
| Revenue | 202.83M |
| Gross Profit | -261.06M |
| Operating Income | -332.40M |
| Pretax Income | -263.15M |
| Net Income | -239.59M |
| EBITDA | -313.08M |
| EBIT | -332.40M |
| Loss Per Share | -$2.90 |
Full Income StatementBalance Sheet
The company has $1.94 billion in cash and $227.55 million in debt, giving a net cash position of $1.71 billion or $20.01 per share.
| Cash & Cash Equivalents | 1.94B |
| Total Debt | 227.55M |
| Net Cash | 1.71B |
| Net Cash Per Share | $20.01 |
| Equity (Book Value) | 1.94B |
| Book Value Per Share | 22.73 |
| Working Capital | 1.85B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$188.82 million and capital expenditures -$2.39 million, giving a free cash flow of -$191.20 million.
| Operating Cash Flow | -188.82M |
| Capital Expenditures | -2.39M |
| Free Cash Flow | -191.20M |
| FCF Per Share | -$2.24 |
Full Cash Flow StatementMargins
Gross margin is -128.71%, with operating and profit margins of -163.88% and -118.13%.
| Gross Margin | -128.71% |
| Operating Margin | -163.88% |
| Pretax Margin | -116.59% |
| Profit Margin | -118.13% |
| EBITDA Margin | -154.36% |
| EBIT Margin | -163.88% |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.11% |
| Shareholder Yield | -5.11% |
| Earnings Yield | -6.89% |
| FCF Yield | -5.50% |
Dividend DetailsAnalyst Forecast
The average price target for CRSP is $76.60, which is 88.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $76.60 |
| Price Target Difference | 88.11% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 39.87% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 8.96 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.96 |
| Piotroski F-Score | 4 |